- Short Report
- Open Access
Characterization of the retinal proteome during rod photoreceptor genesis
BMC Research Notes volume 3, Article number: 25 (2010)
The process of rod photoreceptor genesis, cell fate determination and differentiation is complex and multi-factorial. Previous studies have defined a model of photoreceptor differentiation that relies on intrinsic changes within the presumptive photoreceptor cells as well as changes in surrounding tissue that are extrinsic to the cell. We have used a proteomics approach to identify proteins that are dynamically expressed in the mouse retina during rod genesis and differentiation.
A series of six developmental ages from E13 to P5 were used to define changes in retinal protein expression during rod photoreceptor genesis and early differentiation. Retinal proteins were separated by isoelectric focus point and molecular weight. Gels were analyzed for changes in protein spot intensity across developmental time. Protein spots that peaked in expression at E17, P0 and P5 were picked from gels for identification. There were 239 spots that were picked for identification based on their dynamic expression during the developmental period of maximal rod photoreceptor genesis and differentiation. Of the 239 spots, 60 of them were reliably identified and represented a single protein. Ten proteins were represented by multiple spots, suggesting they were post-translationally modified. Of the 42 unique dynamically expressed proteins identified, 16 had been previously reported to be associated with the developing retina.
Our results represent the first proteomics study of the developing mouse retina that includes prenatal development. We identified 26 dynamically expressed proteins in the developing mouse retina whose expression had not been previously associated with retinal development.
Retinal diseases involving degeneration of photoreceptors are an increasing cause of blindness in this country, particularly among the aging population. Advances in stem cell research may someday make replacement of photoreceptors a feasible therapy for the treatment of retinal degeneration. MacLearen and colleagues  previously reported that only post-mitotic rod precursors were able to successfully and functionally integrate into the mature retina. Currently we are not able to reliably bias stem cells to adopt a photoreceptor fate. In this regard, it will be crucial that we have a clear understanding of the retinal environment during normal photoreceptor genesis as well as the combination of factors both intrinsic and extrinsic to developing retinal cells that influence their decision to adopt a photoreceptor cell fate. To this end we have characterized the developmental proteome of the mouse retina during late embryonic and early postnatal development, the time when the vast majority of rod photoreceptors are born, commit to their cell fate and begin to differentiate.
We have used two-dimensional gel electrophoresis to profile protein expression in developing mouse retinas. Self-organizing mapping (SOM) was used to cluster protein spots into groups based on their changing levels of expression across developmental time. From this we identified clusters of dynamically expressed proteins that peaked in expression at embryonic day 17 (E17; prior to the peak of rod genesis); birth (P0; during the peak of rod genesis) and postnatal day 5 (P5; a time when rods are making irreversible cell fate commitment decisions and have begun to differentiate).
Materials and methods
Pups were taken from timed pregnant C57BL/6 mice at ages E13, E15, E17, E18, P0 and P5. Eyes were enucleated and retinas immediately placed in ice cold Phosphate Buffered Saline (PBS, 0.14 M NaCl, 2.68 mM KCl, 10.14 mM Na2HPO4, 1.76 mM KH2PO4, pH 7.2). The tissue was suspended in rehydration buffer (8 M Urea, 2% CHAPS, 0.5% ZOOM Carrier Ampholytes (Invitrogen, Carlsbad, CA), 0.002% bromophenol blue and 20 mM DTT), sonicated for 30 seconds and spun at 4,000 rpm for 10 minutes at 4°C. The pellet was re-suspended in rehydration buffer (RHB). The sample was spun again at 4,000 rpm for 10 minutes at 4°C. The remaining supernatant was collected and frozen at -80°C. The total protein concentration was determined using the EZQ protein assay (Invitrogen). The sample was diluted to a final concentration of 35 μg per 165 μl (0.212 μg/μl). All experiments were conducted in accordance with the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research.
Two-dimensional separation of protein spots
Proteins were separated on the basis of their isoelectric focus point (pI) using a ZOOM IPGRunner 7 cm strip pH 3-10 (Invitrogen). The total protein loaded on the strip was 35 μg. The first dimension running conditions were as follows: 20 minutes at 200 V, 15 minutes at 450 V, 15 minutes at 750 V and 45 minutes at 2000 V. Proteins were separated by molecular weight using a 7 cm Bis Tris 3-12% pre-cast gel (Invitrogen). The gels were subjected to a continuous voltage of 200 V for 50 minutes.
The gels were fixed with 50% Methanol, 10% Trichloroacetic acid overnight, washed in ddH20 followed by a wash in 10% methanol, 7% acetic acid for 30 minutes. The gels were stained with SYPRO Ruby (Invitrogen) overnight and washed in 10% methanol, 7% acetic acid for 60 minutes followed by dH20 the next morning. They were imaged on a Typhoon 9410 fluorescent scanner (GE Healthcare Life Sciences, Piscataway, NJ) for quantitative analysis and then stained with Simply Blue Coomassie (Invitrogen) overnight to allow hand picking of spots.
For the protein spot detection Phoretix 2D Expression software (Nonlinear Dynamics; Nonlinear USA, Durham, NC) was used. Gels were warped and spots matched automatically by the program but matching was manually checked on all gels and adjusted to correct for incorrect matches. All gels were scrutinized to ensure accurate spot detection and matching, and that artifacts were not counted as actual spots. Three replicates of each age were grouped together to make an average gel for that age. Spots present on at least two of the three gels were included on the average gel for that age group. Expression values for each spot were expressed as protein spot volumes. Background subtraction was employed using the Mode of Non-Spot (default) at a margin of 45 (default). The spot volume was normalized to total spot volume on its average gel.
Clustering of Data
To cluster the data, we used the SOM (Self-Organizing Maps) method provided by the GeneCluster 2.0 . Available at http://www.broad.mit.edu/cancer/software/genecluster2/gc2.html. To preprocess the data, we replaced missing expression values with 0s, interpreting a missing expression value as an absence of a signal, and normalized the data to mean of 0 and variance of 1. The SOM algorithm was executed with the desired cluster range of 6 and the rest of the parameters left unchanged (50000 iterations, seed range of 42, initialization of centroids to random vectors, bubble neighborhood, initial and final learning weights of .1 and .005, and initial and final sigmas determining the size of the update neighborhood of a centroid set to 5 and .5, respectively). This produced 6 clusters with the peak at each time point.
Spot Picking and Identification of Proteins
For protein identification, gels were stained with SimplyBlue (Invitrogen). Spots of interest were hand picked based on clustering results and maps from Phoretix software analysis. Trypsin digestion and deposition to a target for MALDI were performed using an Ettan Spot Handling Workstation (Amersham Biosciences, Newark, NJ, USA). For MALDI analysis, the tryptic peptides dissolved in 50% CH3CN/0.1% TFA were mixed with a matrix solution (CHCA 10 mg/mL in 50% CH3CN/0.1% TFA) and applied on a target plate. For ESI experiments, protein digest solution was taken out after trypsin digestion, extracted and dried to needed volume.
MALDI-TOF MS/MS analyses were performed using a QSTAR XL quadrupole TOF mass spectrometer (AB/MDS Sciex, Toronto, Canada) equipped with an MALDI ion source. The mass spectrometer was operated in the positive ion mode. Mass spectra for MS analysis were acquired over m/z 500 to 4000. After every regular MS acquisition, MS/MS acquisition was performed against most intensive ions. The molecular ions were selected by information dependent acquiring in the quadrupole analyzer and fragmented in the collision cell. For ESI Mass Spectrometry the peptide digest samples were introduced to the QSTAR XL quadrupole TOF mass spectrometer with a Switchos LC pump and a FAMOS autosampler (LC Packings, San Francisco, USA). Other parameters of the mass spectrometer were the same as MALDI analysis.
All spectra were processed by MASCOT (MatrixScience, London, UK) database search. Peak lists were generated by Analyst QS (AB/MDS Sciex, Toronto, Canada) and were used for MS/MS ion searches. Typical search parameters were as follows: Max missing cleavage is one, fixed modification carboxyamidomethyl cysteine, variable modification oxidation of methionine. Peptide mass tolerances were +/- 100 ppm. Fragment mass tolerances were +/- 1 Da. No restrictions on protein molecular weight were applied. Protein identification was based on the probability based Mowse Score. The significance threshold p was set to less than 0.05.
Results and Discussion
As an initial step to better understand rod photoreceptor development we profiled the proteome of the developing mouse retina during the time of maximal rod photoreceptor genesis and cell fate determination. To make the expression analysis more robust, we analyzed retinas from ages embryonic day (E)13, E15, E17 E18 P0 and P5. Representative gels from each age are shown in Figure 1. Expression values for each protein spot were used to cluster spots based on their changing levels of expression from E13 to P5. Figure 2 shows the SOM clustering results when 6 clusters were pre-specified. The resulting clusters contained groups of proteins that had their peak in expression at each of the ages examined. For this analysis, we were most interested in the clusters that contained proteins that peaked at E17, which is just prior to the peak of rod photoreceptor genesis, P0 which is at the peak of rod photoreceptor genesis and P5, which is past the time of rod genesis, but the time when early, irreversible rod differentiation is occurring.
Based on the clustering analysis, spots in cluster 1 (c1; expression peaked at E17), c4 (expression peaked at P0) and c0 (expression peaked at P5) were hand-picked for identification. Of the spots that were picked for analysis, 71.1% (170/239) returned high probability IDs that could be confirmed based on known or predicted molecular weights and isoelectric focus points (pIs). However, some spots returned two different identities, likely because the spots contained both proteins. These spots were not considered further. The resulting dataset, then, included 60 spots, that represented 42 unique proteins. Tables 1, 2 and 3 list the protein spots whose expression peaked at E17, P1 and P5 respectively.
To better understand the proteins that were identified in this analysis, we did a manual literature search to look for published links between each protein and normal retinal development and brain development. Of 60 protein spots whose expression peaked at E17, 16 were identified. Based on a search of the literature, 5 proteins that peaked at E17 had been previously linked to retinal development and 3 to brain development (Table 1 and Figure 3). Of 56 protein spots whose expression peaked at P0, 7 were identified. Based on a search of the literature, 2 proteins had been previously linked to retinal development and 1 to brain development (Table 2 and Figure 4). Of 123 protein spots whose expression peaked at P5, 36 were identified. Based on a search of the literature, 12 had been previously linked to retinal development and 5 to brain development (Table 3 and Figure 5).
This analysis identified 42 distinct proteins that are dynamically expressed in the retina during rod photoreceptor development. Of these proteins, 10 were represented by more than one protein spot, suggesting they are dynamically post-translationally modified. Finally, a manual search of the published literature identified prior published reports had already linked 16 of the 42 proteins to retinal development in some way.
The proteins reported here most certainly do not constitute a complete list of molecules dynamically expressed during development. A number of proteins already demonstrated to be important during photoreceptor development do not appear in our dataset. This could be due to a number of factors including the relative abundance of a protein in the samples, relative change in it's expression levels, high-confidence identification of the protein with MALDI MS/MS, verification of the protein spot ID based on 2D gel position and the protein spot containing a single protein. Thus, while this study reports important results on it's own, we also consider it complimentary to other reports of gene or protein expression in the developing mouse retina.
A number of important studies have used expression analysis to identify genes or proteins expressed in the developing mouse retina [3–8]. The motivation behind this approach is two-fold. Firstly, molecules important for particular events during retinal development may be expected to change at the time that said event is occurring. Secondly, profiling genes that change in relation to one another may help investigators to identify pathways or groups of genes that work together during retinal development. Protein expression profiling can be a powerful compliment to mRNA expression analysis. Changes in protein expression are a more definitive measure of how much gene product is present in cells. However, the most powerful compliment that 2D gel expression analysis offers is the ability to capture not only changes in expression but also changes in post-translational modification. The existence of post-translational modifications can be discovered by differences in pI or molecular weight. In our analysis alone, we identified 10 proteins likely with dynamic post-translational modifications. In future experiments specific dyes for phosphorylation and glycosylation may be useful to identify and quantify specific post-translational modifications.
A previously published complementary study used 2D-gel electrophoresis to profile dynamic changes in protein expression in the postnatal mouse retina . In this study they identified 174 total protein spots. Of the 170 total protein spots that returned identities in the current analysis (E17, P0 and P5), 47 of them were in common with the previous study. Protein expression profiling has also been successfully applied in the developing chick retina [9–11]. Even though these studies may have profiled different ages and/or species it still may be useful to integrate the information from these and other studies to generate a more comprehensive profile of changes in protein expression during vertebrate retinal development.
We have used protein expression profiling to identify retinal proteins with dynamic changes in expression during rod photoreceptor genesis. We identified 16 proteins that have been previously associated with the developing retina and 26 that have not been previously associated with retinal development.
MacLaren RE, Pearson RA, MacNeil A, Douglas RH, Salt TE, Akimoto M, Swaroop A, Sowden JC, Ali RR: Retinal repair by transplantation of photoreceptor precursors. Nature. 2006, 444: 203-207. 10.1038/nature05161.
Reich M, Ohm K, Angelo M, Tamayo P, Mesirov JP: GeneCluster 2.0: an advanced toolset for bioarray analysis. Bioinformatics. 2004, 20: 1797-1798. 10.1093/bioinformatics/bth138.
Blackshaw S, Harpavat S, Trimarchi J, Cai L, Huang H, Kuo WP, Weber G, Lee K, Fraioli RE, Cho SH: Genomic analysis of mouse retinal development. PLoS Biol. 2004, 2: E247-10.1371/journal.pbio.0020247.
Zhang SS, Xu X, Liu MG, Zhao H, Soares MB, Barnstable CJ, Fu XY: A biphasic pattern of gene expression during mouse retina development. BMC Dev Biol. 2006, 6: 48-10.1186/1471-213X-6-48.
Akimoto M, Cheng H, Zhu D, Brzezinski JA, Khanna R, Filippova E, Oh EC, Jing Y, Linares JL, Brooks M: Targeting of GFP to newborn rods by Nrl promoter and temporal expression profiling of flow-sorted photoreceptors. Proc Natl Acad Sci USA. 2006, 103: 3890-3895. 10.1073/pnas.0508214103.
Dorrell MI, Aguilar E, Weber C, Friedlander M: Global gene expression analysis of the developing postnatal mouse retina. Invest Ophthalmol Vis Sci. 2004, 45: 1009-1019. 10.1167/iovs.03-0806.
Liu J, Wang J, Huang Q, Higdon J, Magdaleno S, Curran T, Zuo J: Gene expression profiles of mouse retinas during the second and third postnatal weeks. Brain Res. 2006, 1098: 113-125. 10.1016/j.brainres.2006.04.086.
Haniu H, Komori N, Takemori N, Singh A, Ash JD, Matsumoto H: Proteomic trajectory mapping of biological transformation: Application to developmental mouse retina. Proteomics. 2006, 6: 3251-3261. 10.1002/pmic.200500813.
Finnegan S, Robson JL, Wylie M, Healy A, Stitt AW, Curry WJ: Protein expression profiling during chick retinal maturation: a proteomics-based approach. Proteome Sci. 2008, 6: 34-10.1186/1477-5956-6-34.
Mizukami M, Kanamoto T, Souchelnytskyi N, Kiuchi Y: Proteome profiling of embryo chick retina. Proteome Sci. 2008, 6: 3-10.1186/1477-5956-6-3.
Lam TC, Li KK, Lo SC, Guggenheim JA, To CH: A chick retinal proteome database and differential retinal protein expressions during early ocular development. J Proteome Res. 2006, 5: 771-784. 10.1021/pr050280n.
Chabas A, Briones P, Sabater J: Prenatal human brain development. II. Studies on malate dehydrogenase. Dev Neurosci. 1980, 3: 19-27. 10.1159/000112373.
Zamora DO, Riviere M, Choi D, Pan Y, Planck SR, Rosenbaum JT, David LL, Smith JR: Proteomic profiling of human retinal and choroidal endothelial cells reveals molecular heterogeneity related to tissue of origin. Mol Vis. 2007, 13: 2058-2065.
Alone DP, Tiwari AK, Mandal L, Li M, Mechler BM, Roy JK: Rab11 is required during Drosophila eye development. Int J Dev Biol. 2005, 49: 873-879. 10.1387/ijdb.051986da.
Nakazawa T, Nakano I, Furuyama T, Morii H, Tamai M, Mori N: The SCG10-related gene family in the developing rat retina: persistent expression of SCLIP and stathmin in mature ganglion cell layer. Brain Res. 2000, 861: 399-407. 10.1016/S0006-8993(00)02056-4.
Hasegawa A, Hisatomi O, Yamamoto S, Ono E, Tokunaga F: Stathmin expression during newt retina regeneration. Exp Eye Res. 2007, 85: 518-527. 10.1016/j.exer.2007.07.003.
Knoops B, Octave JN: Alpha 1-tubulin mRNA level is increased during neurite outgrowth of NG 108-15 cells but not during neurite outgrowth inhibition by CNS myelin. Neuroreport. 1997, 8: 795-798. 10.1097/00001756-199702100-00043.
Hotulainen P, Llano O, Smirnov S, Tanhuanpaa K, Faix J, Rivera C, Lappalainen P: Defining mechanisms of actin polymerization and depolymerization during dendritic spine morphogenesis. J Cell Biol. 2009, 185: 323-339. 10.1083/jcb.200809046.
Nielsen MD, Luo X, Biteau B, Syverson K, Jasper H: 14-3-3 Epsilon antagonizes FoxO to control growth, apoptosis and longevity in Drosophila. Aging Cell. 2008, 7: 688-699. 10.1111/j.1474-9726.2008.00420.x.
McConnell JE, Armstrong JF, Hodges PE, Bard JB: The mouse 14-3-3 epsilon isoform, a kinase regulator whose expression pattern is modulated in mesenchyme and neuronal differentiation. Dev Biol. 1995, 169: 218-228. 10.1006/dbio.1995.1139.
Hernandez G, Vazquez-Pianzola P, Zurbriggen A, Altmann M, Sierra JM, Rivera-Pomar R: Two functionally redundant isoforms of Drosophila melanogaster eukaryotic initiation factor 4B are involved in cap-dependent translation, cell survival, and proliferation. Eur J Biochem. 2004, 271: 2923-2936. 10.1111/j.1432-1033.2004.04217.x.
Yanase H, Shimizu H, Yamada K, Iwanaga T: Cellular localization of the diazepam binding inhibitor in glial cells with special reference to its coexistence with brain-type fatty acid binding protein. Arch Histol Cytol. 2002, 65: 27-36. 10.1679/aohc.65.27.
Godbout R, Bisgrove DA, Shkolny D, Day RS: Correlation of B-FABP and GFAP expression in malignant glioma. Oncogene. 1998, 16: 1955-1962. 10.1038/sj.onc.1201740.
Kurtz A, Zimmer A, Schnutgen F, Bruning G, Spener F, Muller T: The expression pattern of a novel gene encoding brain-fatty acid binding protein correlates with neuronal and glial cell development. Development. 1994, 120: 2637-2649.
Allen GW, Liu J, Kirby MA, De Leon M: Induction and axonal localization of epithelial/epidermal fatty acid-binding protein in retinal ganglion cells are associated with axon development and regeneration. J Neurosci Res. 2001, 66: 396-405. 10.1002/jnr.1232.
Liu Y, Longo LD, De Leon M: In situ and immunocytochemical localization of E-FABP mRNA and protein during neuronal migration and differentiation in the rat brain. Brain Res. 2000, 852: 16-27. 10.1016/S0006-8993(99)02158-7.
Blanchette AR, Fuentes Medel YF, Gardner PD: Cell-type-specific and developmental regulation of heterogeneous nuclear ribonucleoprotein K mRNA in the rat nervous system. Gene Expr Patterns. 2006, 6: 596-606. 10.1016/j.modgep.2005.11.008.
Thummel R, Burket CT, Hyde DR: Two different transgenes to study gene silencing and re-expression during zebrafish caudal fin and retinal regeneration. Scientific World Journal. 2006, 6 (Suppl 1): 65-81.
Ruchhoeft ML, Harris WA: Myosin functions in Xenopus retinal ganglion cell growth cone motility in vivo. J Neurobiol. 1997, 32: 567-578. 10.1002/(SICI)1097-4695(19970605)32:6<567::AID-NEU3>3.0.CO;2-Y.
Insua MF, Garelli A, Rotstein NP, German OL, Arias A, Politi LE: Cell cycle regulation in retinal progenitors by glia-derived neurotrophic factor and docosahexaenoic acid. Invest Ophthalmol Vis Sci. 2003, 44: 2235-2244. 10.1167/iovs.02-0952.
The authors wish to thank Nada Pavlovic in the Department of Biomedical Sciences for technical support and Dr. William Lewis at the Iowa State University Proteomics Facility for assistance. This study was funded by a grant to MHWG, VH and JB (NIH EY014931).
The authors declare that they have no competing interests.
AB and LH carried out the protein expression profiling, OK did the clustering analysis, JB participated in the experimental design and facilitated the protein expression profiling, VH participated in the experimental design and data analysis, MHWG conceived of the study, participated in the design and coordination and helped draft the manuscript. All authors read and approved the final manuscript.